mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
In addition to laser photocoagulation, therapeutic interventions for diabetic retinopathy (DR) have heretofore consisted of anti-VEGF drugs, which, besides drawbacks inherent to the treatments themselves, are limited in scope and may not fully address the condition’s complex pathophysiology. This is...
Main Authors: | Steven Hyun Seung Lee, Joo Yong Lee, Jun-Sub Choi, Hee Jong Kim, Jin Kim, Seho Cha, Kyoung Jin Lee, Ha-Na Woo, Keerang Park, Heuiran Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202865/?tool=EBI |
Similar Items
-
mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy.
by: Steven Hyun Seung Lee, et al.
Published: (2022-01-01) -
Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization
by: Tae Kwann Park, et al.
Published: (2017-09-01) -
A Single Injection of rAAV-shmTOR in Peripheral Nerve Persistently Attenuates Nerve Injury-Induced Mechanical Allodynia
by: Minkyung Park, et al.
Published: (2023-11-01) -
scAAV2-Mediated Expression of Thioredoxin 2 and C3 Transferase Prevents Retinal Ganglion Cell Death and Lowers Intraocular Pressure in a Mouse Model of Glaucoma
by: Hee Jong Kim, et al.
Published: (2023-11-01) -
mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy
by: Sanjar Batirovich Madrakhimov, et al.
Published: (2021-02-01)